<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Научные результаты биомедицинских исследований</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2313-8955-2016-2-4-4-12</article-id><article-id pub-id-type="publisher-id">863</article-id><article-categories><subj-group subj-group-type="heading"><subject>Клиническая медицина</subject></subj-group></article-categories><title-group><article-title>СОВРЕМЕННЫЕ ПРЕДСТАВЛЕНИЯ О ЭПИДЕМИОЛОГИИ И ПАТОГЕНЕЗЕ УРОЛИТИАЗА</article-title><trans-title-group xml:lang="en"><trans-title>MODERN RESEARCH AND THINKING ABOUT THE EPIDEMIOLOGY AND PATHOGENESIS OF UROLITHIASIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Шкодкин</surname><given-names>Сергей Валентинович</given-names></name><name xml:lang="en"><surname>Shkodkin</surname><given-names>Sergey V.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Батищев</surname><given-names>Сергей Александрович</given-names></name><name xml:lang="en"><surname>Batishchev</surname><given-names>Sergey A.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Невский</surname><given-names>Александр Александрович</given-names></name><name xml:lang="en"><surname>Nevskiy</surname><given-names>Alexander A.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Фиронов</surname><given-names>Сергей Александрович</given-names></name><name xml:lang="en"><surname>Fironov</surname><given-names>Sergey A.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Золотухин</surname><given-names>Дмитрий Анатольевич</given-names></name><name xml:lang="en"><surname>Zolotukhin</surname><given-names>Dmitry A.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Челпан</surname><given-names>Валерия Федоровна</given-names></name><name xml:lang="en"><surname>Chelpan</surname><given-names>Valeriya F.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Куликовский</surname><given-names>Владимир Федорович</given-names></name><name xml:lang="en"><surname>Kulikovskii</surname><given-names>Vladimir F.</given-names></name></name-alternatives><email>kulikovsky@bsu.edu.ru</email></contrib></contrib-group><pub-date pub-type="epub"><year>2016</year></pub-date><volume>2</volume><issue>4</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2016/4/Медицина_и_фармация_-4-12.pdf" /><abstract xml:lang="ru"><p>Мочекаменная болезнь занимает второе место в структуре урологической заболеваемости, уступая позицию только инфекционно-воспалительной патологии органов мочевой системы. По состоянию на 2010 год распространённость мочекаменной болезни (МКБ) в США составляет примерно 14%, в России &amp;ndash; 5,7%, в Испании &amp;ndash; 5,6%, в Бразилии &amp;ndash; 5%, в Тайвани &amp;ndash; 7,4%, в Турции &amp;ndash; 14,8%, а в странах аравийского полуострова (Саудовская Аравия и Объединенные Арабские Эмираты) распространённость уролитиаза достигает &amp;gt;20%. При этом, заболеваемость этой патологией с каждым годом стремительно увеличивается, не смотря на достижения медицины. Этому могут способствовать такие факторы риска, как: урбанизация населения, гиподинамия, частые стрессовые ситуации, погрешности в питании, ухудшение состояния окружающей среды. Таким образом, мочекаменная болезнь является одной из наиболее важных и экономически значимых проблем не только в урологии, но и смежных отраслях медицины, поскольку требует мультидисциплинарного подхода к диагностике, лечению и профилактике. А четкое понимание факторов риска уролитиаза и вероятного механизма литогенеза позволит исследователям и практикующим врачам более осмыслено подходить к лечению и профилактике данной патологии.</p></abstract><trans-abstract xml:lang="en"><p>Urolithiasis ranks second in the urologic incidence, being preceded only by infectious and inflammatory diseases of the urinary system. In 2010, the prevalence of urolithiasis in the US was approximately 14%, in Russia - 5.7%, in Spain - 5.6%, in Brazil - 5%, in Taiwan - 7.4%, in Turkey - 14.8%, and in the countries of the Arabian Peninsula (Saudi Arabia and the United Arab Emirates) the prevalence of urolithiasis reached more than 20%. At the same time the incidence of this disease is growing rapidly every year, in spite of the progress in medical science. This may be explained by the risk factors such as urbanization, lack of exercise, frequent stressful situations, errors in dietary habits, and environmental degradation. Thus, urolithiasis is one of the most important and economically significant problems not only in urology but also in related fields of medicine, because it requires a multidisciplinary approach to diagnosis, treatment and prevention. A clear understanding of the risk factors of urolithiasis and possible lithogenesis mechanism will allow researchers and clinicians to have a more sensible approach to the treatment and prevention of this disease.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>уролитиаз</kwd><kwd>эпидемиология</kwd><kwd>структура камня</kwd><kwd>патогенез</kwd></kwd-group><kwd-group xml:lang="en"><kwd>urolithiasis</kwd><kwd>epidemiology</kwd><kwd>stone composition</kwd><kwd>pathogenesis</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Авдошин В.П., Андрюхин М.И., Ольшанская Е.В. Парентеральная литолитическая терапия уратного уролитиаза // Урология (приложение). 2008. №4. 5с.</mixed-citation></ref><ref id="B2"><mixed-citation>Аль-Шукри С.Х., Голощапов Е.Т., Эмануэль Ю.В., Горбачев М. И. Новые патогенетические подходы в понимании механизмов лито‑ генеза при билатеральном рецидивирующем нефролитиаза // Бюллетень медицинских интернет‑конференций. 2011. Т. 1. № 4. С. 66&amp;ndash;75</mixed-citation></ref><ref id="B3"><mixed-citation>Аляев Ю.Г., Кузъмичева Г.М., Колесникова М.О. Клиническое значение физико-химического исследования состава мочевых камней и мочи // Урология. 2009. №1. С. 8-11.</mixed-citation></ref><ref id="B4"><mixed-citation>Аляев Ю.Г., Руденко В.И., Газимиев М.С. Мочекаменная болезнь. Актуальные вопросы диагностики и выбора метода лечении. - М. - Тверь: &amp;laquo;Триада&amp;raquo;, 2006. 236с.</mixed-citation></ref><ref id="B5"><mixed-citation>Государственный доклад о состоянии здоровья населения Российской Федерации за 2009-2014 год. &amp;ndash; М.:ГЭОТАР-МЕД, 2001-2014.&amp;nbsp; 48 с.</mixed-citation></ref><ref id="B6"><mixed-citation>Комяков Б.К., Акимов А.Н., Новиков А.И. Коралловидный нефролитиаз // Terra Medica.&amp;nbsp; 2013. № 2.&amp;nbsp; С. 53.</mixed-citation></ref><ref id="B7"><mixed-citation>Павлов В. Н.,&amp;nbsp; Алексеев А.В., Гитиятуллина Р.С., Ишемгулов Р.Р., Мустафин А.Т. Состояние водно-электролитного и азотистого обмена у пациентов с мочекаменной болезнью после дистанционной нефролитотрипсии // Медицинский вестник Башкоркостана.&amp;nbsp; 2011. Том 6. №2. С. 116 &amp;ndash; 119.</mixed-citation></ref><ref id="B8"><mixed-citation>Хасигов А.В. Эффективность перкутанной нефролитотоми в связи с особенностями патогенеза, профилактики коралловидного нефролитиаза в эндемических зонах Юга России: Автореф. дис. &amp;hellip; д-ра мед. наук. Ростов-на-Дону, 2014.- 36 с</mixed-citation></ref><ref id="B9"><mixed-citation>Arias F&amp;uacute;nez F., Garc&amp;iacute;a Cuerpo E., Lovaco Castellanos F., Escudero Barrilero A., Avila Padilla S. Epidemiology of urinary lithiasis in our Unit. Clinical course in time and predictive factors. Arch Esp Urol. 2000. 53. Pp. 343-7.</mixed-citation></ref><ref id="B10"><mixed-citation>Bae S.R., Seong J.M., Kim L.Y. The epidemiology of renoureteral stone disease in Koreans: a nationwide population-based study. Urolithiasis. 2014. 42. Pp. 109-14.</mixed-citation></ref><ref id="B11"><mixed-citation>Basiri A., Shakhssalim N., Khoshdel A.R., Ghahestani S.M., Basiri H. The demographic profile of urolithiasis inIran: a nationwide epidemiologic study. Int Urol Nephrol. 2010. 42. Pp. 119-26.</mixed-citation></ref><ref id="B12"><mixed-citation>Basiri A., Shakhssalim N., Khoshdel A.R. Familial relations and recurrence pattern in nephrolithiasis: new words about old subjects. Urol J 2010. 7(2). Pp. 81-87.</mixed-citation></ref><ref id="B13"><mixed-citation>Calcium oxalate monohydrate aggregation induced by aggregation of desialylated Tamm-Horsfall protein./Viswanathan P., Rimer J.D., Kolbach A.M., Ward MD, Kleinman J.G., Wesson J.A./Urol Res. 2011. 39(4). Pp. 269-82.</mixed-citation></ref><ref id="B14"><mixed-citation>Fisang C., Anding R., M&amp;uuml;ller S.C., Latz S., Laube N. Urolithiasis--an interdisciplinary diagnostic, therapeutic and secondary preventive challenge. Dtsch Arztebl Int. 2015. 112. Pp. 83-91.</mixed-citation></ref><ref id="B15"><mixed-citation>Gault M.H., Chafe L. Relationship of frequency, age, sex, stone weight and composition in 15 624 stones: comparison of results for 1980 to 1983 and 1995 to 1998. J Urol. 2000. 164. Pp. 302&amp;ndash;7.</mixed-citation></ref><ref id="B16"><mixed-citation>Guidelines on Urolithiasis: Eur Urol / C. T&amp;uuml;rk, T. Knoll, Petrik A., Sarica K., Skolarikos A., Straub M., Seitz C. 2014. Pp. 71p.</mixed-citation></ref><ref id="B17"><mixed-citation>Hesse A., Br&amp;auml;ndle E., Wilbert D., K&amp;ouml;hrmann K-U., Alken P. Study on the prevalence and incidence of Urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol. 2003. 44. Pp. 70913.</mixed-citation></ref><ref id="B18"><mixed-citation>Lee M.C., Bariol S.V. Changes in upper urinary tract stonecomposition in Australia over the past 30 years. BJU Int. 2013. 112 (Suppl 2). Pp. 65-68.</mixed-citation></ref><ref id="B19"><mixed-citation>Mi&amp;ntilde;&amp;oacute;n Cifuentes, Pourmand G. Mineral composition of 103 stones from Iran. Br J Urol. 1983. 55. Pp. 465-473</mixed-citation></ref><ref id="B20"><mixed-citation>Phytate acts as an inhibitor in formation of renal calculi. Grases , Isern , Sanchis P., Perello J., Torres J.J., Costa-Bauza A. Front Biosci. 2007. 12. Pp. 2580-7.</mixed-citation></ref><ref id="B21"><mixed-citation>Pourmand G, Pourmand B. Epidemiology of Stone Disease in Iran. In: Urolithiasis. London: Springer-Verlag; 2012. Pp. 85-7.</mixed-citation></ref><ref id="B22"><mixed-citation>Prezioso D., Illiano E., Piccinocchi G., et al. Urolithiasis in Italy: an epidemiological study. Arch Ital Urol Androl. 2014. 86. Pp. 99-102.</mixed-citation></ref><ref id="B23"><mixed-citation>Riley, M.J., Kim H.J., Averch T.D., Kim H. Applying theoretical chemistry to the study of calcium oxalate nephrolithiasis. J of Endourology (Supl.). 2012. Vol. 26.&amp;nbsp; Рp. A. 2-3.</mixed-citation></ref><ref id="B24"><mixed-citation>Robertson W.G.. Stone formation in the Middle Eastern Gulf States: A review. Arab J Urol. 2012.10. Pp. 265-72.</mixed-citation></ref><ref id="B25"><mixed-citation>Romero V., Akpinar H., Assimos D.G. Kidney calculi: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010 .12. Pp. e86-96.</mixed-citation></ref><ref id="B26"><mixed-citation>S&amp;aacute;nchez-Martin F.M., Mill&amp;aacute;n Rodr&amp;iacute;guez F., Esquena Fern&amp;aacute;ndez S. Incidencia y prevalencia de la urolithiasis en Espana: revision de los datos originales disponibles hasta la actualidad. Actas Urol Esp. 2007. 31. Pp. &amp;nbsp;511-20.</mixed-citation></ref><ref id="B27"><mixed-citation>Scales C.D. Jr, Smith A.C., Hanley J.M., Saigal C.S. Prevalence of kidney calculi in the United States. Urologic Diseases in America Project. Eur Urol. 2012. 62. Pp. 160-5.</mixed-citation></ref><ref id="B28"><mixed-citation>Sorensen M.D., Chi T., Shara N.M., Wang H., Hsi R.S., Orchard T. Activity, energy intake, obesity, and the risk of incident kidney stones in postmenopausal women: a report from the Women&amp;rsquo;s Health Initiative. J Am Soc Nephrol. 2014. 25. Pp. 362-369.</mixed-citation></ref><ref id="B29"><mixed-citation>Sreenevasan G. Urinary stones in Malaysia- its incidence and management. Med J Malaysia. 1990. 45. Pp. &amp;nbsp;92-112.</mixed-citation></ref><ref id="B30"><mixed-citation>Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney calculi in the United States: 1976&amp;ndash;1994. Kidney Int. 2003. 63. Pp. 1817-23.</mixed-citation></ref><ref id="B31"><mixed-citation>Sun B., Shi J., Dong H. Epidemiological investigation of urolithiasis in Congjiang county in Guizhou. Guizhou Yi Yao. 1989.13. Pp. 231-2.</mixed-citation></ref><ref id="B32"><mixed-citation>Taylor E., Stampfer M., Curhan G. Obesity, weight gain, and the risk of kidney stones. JAMA 2005. 293. Pp. 455&amp;ndash;62.</mixed-citation></ref><ref id="B33"><mixed-citation>Turney B.W., Reynard J.M., Noble J.G., Keoghane S.R. Trends in urological stone disease BJU Int. 2012. 109. Pp. 1082-7.</mixed-citation></ref><ref id="B34"><mixed-citation>Walsh G. et al. Сampbell&amp;rsquo;s operative urology.- 7 th Ed., 1998.V.5. Pp. 562-600.</mixed-citation></ref><ref id="B35"><mixed-citation>World Population Prospects: The 2012 Revision. United Nations, Department of Economic and Social Affairs, Population Division. 2013</mixed-citation></ref><ref id="B36"><mixed-citation>Yasui T., Iguchi M., Suzuki S., Kohri K. Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urology.2008.71. Pp. 209-13.</mixed-citation></ref><ref id="B37"><mixed-citation>Zeng Q., He Y. Age-specific prevalence of kidney calculi in Chinese urban inhabitants. Urolithiasis. 2013. 41. Pp. 91-93.</mixed-citation></ref></ref-list></back></article>